Skip to main content

Table 7 Concomitant non-psychiatric medication at baseline (FAS, N = 642)

From: Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study

Medication

n (%)

None

502 (78.44%)

Statins

12 (1.88%)

Other hypolipidemic drugs

8 (1.25%)

Beta-blockers

62 (9.69%)

Diuretics

24 (3.75%)

Ca-antagonists

10 (1.56%)

ACE-inhibitors

32 (5.00%)

Angiotensin-II-antagonists

2 (0.31%)

Other antihypertensive drugs

22 (3.44%)

Insulins

9 (1.41%)

Oral anti-diabetic drugs

23 (3.59%)

Oral corticosteroids

1 (0.16%)

Corticosteroid inhalants

3 (0.47%)

  1. Abbreviations: ACE-inhibitors = angiotensin-converting enzyme inhibitors; FAS = full analysis set